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Abstract: The ester functionality is commonly seen in the
areas of chemical biology and medicinal chemistry for the
design of cell-permeable active molecules. Ester-based pro-
drug/pro-sensor strategies are employed to mask polar
functional groups (i. e. carboxylic acids) and improve the
overall cell permeability of these functional molecules.
However, their use as reactive units for sensing applications,
including bacterial detection, has not been fully explored.
Herein, we synthesised two TCF-based fluorescent probes,
TCF-OAc and TCF-OBu. As expected, both TCF-OAc and
TCF-OBu demonstrated a significant fluorescence (22- and
43-fold, respectively) and colorimetric response (yellow to
purple) towards porcine liver esterase (PLE) with a limit of
detection of 1.18 mU/mL and 0.45 mU/mL, respectively.
With these results in hand, the ability of these probes to
detect planktonic suspensions of gram-positive Staphylococ-
cus aureus (S. aureus) and gram-negative Pseudomonas
aeruginosa (P. aeruginosa), and Escherichia coli (E. coli) were
evaluated. Different fluorescence responses for gram-positive
and gram-negative bacteria were observed between TCF-OAc
and TCF-OBu. After 1 h incubation, TCF-OAc proved more
sensitive towards S. aureus, demonstrating a significant
fluorescence “turn on” response (16-fold); whereas, TCF-
OBu was more selective towards P. aeruginosa, with a 22-fold
increase in the fluorescence response observed. These
results demonstrate the influence of the ester chain length
on the selectivity for bacterial species.
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Wound infections pose a significant risk to patients’ health and
are a financial burden to health care systems.[1] Routine
microbiological analysis is needed for the accurate diagnosis
of wound infections; however, these procedures are often slow
and labour intensive.[2] Therefore, clinicians tend to diagnose
wound infections through the observation of clinical
indicators.[3] Unfortunately, this can lead to the misuse of
antibiotics, which results in the development of antibiotic
resistant bacteria.[4] To overcome these clinical challenges, the
development of easy-to-use diagnostic devices for the accurate
and rapid detection of pathogenic bacteria is highly desired.[5]
Recent diagnostic methods include enzyme-linked immuno-
sorbent assays (ELISA),[6] polymerase chain reaction (PCR)-
based methods,[7] DNA arrays,[8] and mass spectrometric
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analysis.[9] However, these expensive and invasive methods
require specialised and trained personnel.
An attractive alternative is the use of small molecule
fluorescent and colorimetric probes because they are simple to
use, highly sensitive, low in cost, easy to handle, can be used
by a non-specialist and have fast detection times.[10] In
addition, they offer a complementary strategy to smart wound
technologies and point of care (PoC) devices.[11] Current small-
molecule fluorescent probes utilise enzyme-based biomarkers
to facilitate the detection of pathogenic bacteria,[12] which
include elastases,[10e] phosphatases,[13] glycosidases,[14]
proteases[15] and lipases.[16]
Ester functionalisation is commonly used in medicinal
chemistry and chemical biology for the masking of polar
alcohol and carboxylic acid functionalities on therapeutics or
sensors to afford cell permeable pro-molecules.[17] Upon
cellular uptake, these ester pro-molecules are expected to
cleave by a range of cellular esterases and release the active
molecule. However, recent studies have found various
bacterial species exhibit significant substrate specificity for
ester functionalities, which can influence the efficacy of a
particular therapeutic.[17a] With this knowledge in hand, we
expected that ester functionalised fluorescent probes differing
in alkyl chain length may confer a level of selectivity for the
detection of bacterial species. Here, we synthesised and
evaluated two 2-dicyanomethylene-3-cyano-4,5,5-trimethyl-
2,5-dihydrofuran (TCF)-based probe TCF-OAc (previously
reported for hydrazine detection)[18] and the novel TCF-OBu)
for the fluorescent and colorimetric detection of bacterial
species. The ester deprotection (esterase-mediated and bacte-
rial-mediated) of TCF-OAc and TCF-OBu results in the
release of the donor-π-acceptor (D-π-A) system TCF-OH,[19]
which affords an ideal long fluorescence emission wavelength
(~600 nm) accompanied by a colorimetric change from yellow
to purple (Scheme 1).[20]
In brief, TCF-OAc and TCF-OBu were synthesised
through the simple acylation of TCF-OH using acetyl chloride
and butyryl chloride, respectively - see supporting information
for full details. With each probe in hand, UV-Vis and
fluorescence titrations were carried out using porcine liver
esterase (PLE). 10% DMSO was required to provide good
aqueous solubility for TCF-OAc and TCF-OBu. As expected,
the addition of PLE to both TCF-OAc and TCF-OBu resulted
in a clear bathochromic shift from 450 nm to 570 nm, and a
significant turn-on fluorescence response at 606 nm, which
was indicative of the formation of TCF-OH (Figures 1 and
S1–S4). This PLE mediated hydrolysis of TCF-OAc and
TCF-OBu to TCF-OH was further confirmed by high
resolution mass spectrometry (HRMS), Tables S2–S4, Figur-
es S3 and S4. As shown in Figure 1, a dose-dependent increase
in fluorescence intensity were observed for TCF-OAc and
TCF-OBu with the addition of PLE (0–0.4 U/mL). Interest-
ingly, TCF-OBu was found to have the greatest sensitivity
with a limit of detection (LOD) of 0.45 mU/mL compared to
TCF-OAc with a LOD of 1.18 mU/mL (Figures 1C and 1D,
Tables S5 and S6). Kinetics of both TCF-OAc and TCF-OBu
towards PLE were determined using the spectroscopic data
and the Michaelis-Menten equation. This revealed a Km of
7.21�0.74 μM and a Vmax of 1333�73.64 min  1 for TCF-
OAc, and a Km of 27.51�2.602 μM and a Vmax of 15196�
1118 min  1 for TCF-OBu, indicating a greater affinity of PLE
towards TCF-OAc over TCF-OBu (Figure S9–S12 and
Scheme 1. Colorimetric and fluorescent TCF-based probes, TCF-OAc and TCF-OBu, for the detection of bacteria.
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Tables S5–S9). This is reflected in the selectivity when both
probes were screened against other enzymes and biological
analytes (Figure S13–S15).
Upon determining the enzyme-responsive nature of both
TCF-OAc and TCF-OBu, their ability to detect pathogenic
bacteria was evaluated (Figure 2). In this study, three common
bacterial pathogens: S. aureus, E. coli, and P. aeruginosa were
used, which include clinical and commercial strains (Ta-
ble S1). Each bacterial isolate was grown in tryptic soy broth
(TSB) for 24 h at 37 °C, standardised to c. 108 CFU/mL,
centrifuged, and resuspended in phosphate buffered saline
(PBS with 10% DMSO, pH 7.4) containing TCF-OAc/TCF-
OBu (10 μM). After 1 h incubation of TCF-OAc with gram-
positive S. aureus MRSA252 and NCTC 10788, significant
increases in fluorescence intensity was observed (One-way
ANOVA, p<0.0001 for both; 11- and 16-fold, respectively).
This increase in fluorescence intensity was approximately 2-
fold higher than TCF-OBu when incubated with the same
bacterial isolates (6- and 9-fold, respectively). Conversely,
TCF-OBu was found to be more selective towards gram-
negative P. aeruginosa PAO1 and P885 with a 22-fold increase
in fluorescence intensity seen for both strains (One-way
ANOVA, p<0.0001 for both). This response was approx-
imately 4-fold higher than TCF-OAc when incubated with the
same strains (6- and 4-fold, respectively). Interestingly, E. coli
DH5α and NSM59 elicited a response comparable to the
negative control for both TCF-OAc and TCF-OBu. To ensure
that each probe had no influence on the viability of the
bacteria, toxicity studies were performed. As shown in
Figures S16 and S17, the bacterial cell density remained stable
upon incubation and no clinically significant decrease in
bacterial cell counts were observed for both TCF-OAc and
TCF-OBu (t-test; p<0.05); demonstrating the suitability of
these probes for diagnostic applications. We believe the
selectivity observed could be due to a number of factors
including slow cellular uptake, difference in enzyme/bacteria
recognition, and local environmental conditions (i.e. pH and
PBS), although more research is needed to identify the exact
reason for these selectivity differences. However, the current
results illustrate that subtle changes in the ester chain length
has a significant impact on the bacterial selectivity of the
fluorescent probes under these conditions. This finding is of
particular significance as developing a fluorescent probe that
is selective for a particular bacterial species could aid
diagnosis and enable the rapid provision of appropriate
antibiotic treatments, which should minimalize the potential
for the development of drug resistant bacteria.
Figure 1. Fluorescence spectra of a) TCF-OAc (10 μM) and b) TCF-OBu (10 μM) with the addition of PLE (0–0.4 U/mL). Relative fluorescence
intensity of c) TCF-OAc and d) TCF-OBu with the addition of PLE (0–0.4 U/mL) at 606 nm, error bars indicate the standard deviation. The
measurements were made 15 min after PLE addition in PBS buffer, 10% DMSO pH=7.4 at 25 °C, λex=542 (bandwidth 15) nm.
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In conclusion, we have synthesised and evaluated two
fluorescent probes, TCF-OAc and the novel TCF-OBu for
evaluation against bacterial pathogens. Both TCF-OAc and
TCF-OBu were shown to have a clear concentration-depend-
ent fluorescence increase and an obvious colour change from
yellow to purple in the presence of PLE model. TCF-OBu
demonstrated a lower limit of detection compared to TCF-
OAc (1.13 and 0.45 mU/mL, respectively), whereas, TCF-
OAc displayed an enhanced selectivity towards esterases.
TCF-OAc displayed the greatest selectivity towards S. aureus,
while TCF-OBu displayed an enhanced selectivity towards P.
aeruginosa. Interestingly, no effect was observed upon
incubation with E. coli. These results illustrate that subtle
changes to the ester chain length of ester-functionalised
fluorescent probes have a significant influence on their ability
to detect and distinguish pathogenic bacteria. We are currently
exploring these probes in hydrogel systems for the develop-
ment of smart wound dressings.
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